Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CG7870 and Docetaxel in Metastatic Hormone-Refractory Prostate Cancer
NCT00103428Phase 2Terminated
- Sponsor
- Cell Genesys
- Start
- Aug 2004
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of CG7870 in prostate cancer (PCa), sponsored by Cell Genesys. Started Aug 2004; status: terminated.
02
Drugs
CG7870
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00103428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103428.